Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation.

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2013
This article has no abstract
Epistemonikos ID: d0f15a0b0adff7c361606561710363106a004bd2
First added on: Jan 22, 2025